by Geoffrey Grinder, Now The End Begins:
Synchron’s device, once implanted, travels to the brain through blood vessels. (Neuralink’s is implanted directly into the skull.) After it reaches the brain, the Stentrode translates brain activity into signals designed to allow texting, emailing, online shopping or other activities using an external device, Synchron said.
TRUTH LIVES on at https://sgtreport.tv/
Wow, I know you got a lot on your end times plate, what with nuclear war looming in Russia, the coming ANTIFA riots this summer, the overturning of abortion in America, the Internet of Bodies in the Fourth Industrial Revolution and so much more, but I have to add one more tiny, little thing to the lineup today. Seems that tech company Synchron has beaten Elon Musk and Neuralink to clinical human trials of an implantable device that will allow your brain to directly interact with your mobile device. Just wondering if it will go in the forehead or not. Why don’t you pour yourself a nice, hot cup of coffee and watch ‘Songbird’ while you think about it.
“And he causeth all, both small and great, rich and poor, free and bond, to receive a mark in their right hand, or in their foreheads: And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name.” Revelation 13:16,17 (KJB)
Human implantable devices to connect your body with the internet is the fastest-growing tech sector in the world today, it is a multi-billion dollar industry. You know those digital IDs that Emmanuel Macron is forcing all his subjects to receive? That is what we call a harbinger of things to come. When you realize that all the events of the Plannedemic were designed to get you to the place where you willing accept implantable devices, you have left the headlines and hopped onto scripture.
The First Commercial Brain Computer Interface Is Entering Human Trials
FROM BLOOMBERG NEWS: The early feasibility study is funded by the National Institutes of Health and will evaluate the safety of the device, known as the Stentrode, the New York-based company said. It will also assess how effective the Stentrode is in helping patients control digital devices hands-free.
The trial represents a landmark for Synchron, the first startup working on brain-machine interfaces to begin a clinical trial seeking approval to sell its product. It also puts Synchron ahead of Neuralink, which is better funded but is still recruiting a trial director. Neuralink raised $205 million last year. Synchron has raised $70 million total.
Brain-computer interfaces, or BCI, could empower millions of disabled people to more easily communicate and engage in modern life. Paralysis affects more than 5 million people in the U.S. alone, according to researchers at the Centers for Disease Control. Farther in the future, Musk and other technologists talk of a world where anyone could receive implants to achieve a sort of superintelligence.
Synchron’s device, once implanted, travels to the brain through blood vessels. (Neuralink’s is implanted directly into the skull.) After it reaches the brain, the Stentrode translates brain activity into signals designed to allow texting, emailing, online shopping or other activities using an external device, Synchron said. READ MORE
Meet The Synchron Human Implantable Brain Computer Device
Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the Stentrode™ brain-computer interface (BCI), or neuroprosthesis.